A phase 2b clinical trial testing the efficacy of the anticancer drug tremelimumab for the treatment of relapsed malignant mesothelioma found that the drug...
Pediatric brain tumors remain difficult to treat which results in the highest deaths among all pediatric malignancies.
Researchers at Stanford University found that antibody-based blockade...
Recent Comments